EUVIMEDEUVIMED entdecken
Open Access

Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test

David L Walker, Michael Davis

Learning & Memory · 2008-02 · 15 (2) · 67-74

DOI: 10.1101/lm.798908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Learning & Memory, online erschienen am 28.01.2008. Verfasst von David L Walker und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory University, Atlanta, Georgia 30329, USA. dlwalke@emory.edu. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Within the amygdala, most N -methyl-D-aspartic acid (NMDA) receptors consist of NR1 subunits in combination with either NR2A or NR2B subunits. Because the particular subunit composition greatly influences the receptors’ properties, we investigated the contribution of both subtypes to fear conditioning and expression. To do so, we infused the NR1/NR2B receptor antagonist CP101,606 (0.5, 1.5, or 4.5 μg/amygdala) or the NR1/NR2A-preferring antagonist NVP-AAM077 (0.075, 0.25, 0.75, or 2.5 μg/amygdala) into the amygdala prior to either fear conditioning (i.e., light-shock pairings) or fear-potentiated startle testing. CP101,606 nonmonotonically disrupted fear conditioning but did not disrupt fear expression. NVP-AAM077 dose-dependently disrupted fear conditioning as well as fear expression. The results suggest that amygdala NR1/NR2B receptors play a special role in fear memory formation, whereas NR1/NR2A receptors participate more generally in synaptic transmission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmygdalaAnimalsConditioning, PsychologicalDose-Response Relationship, DrugFearMalePiperidinesQuinoxalinesRatsRats, Sprague-DawleyReceptors, N-Methyl-D-AspartateReflex, Startle

Substanzen

PiperidinesQuinoxalinesReceptors, N-Methyl-D-Aspartate5-(alpha-methyl-4-bromobenzylamino)phosphonomethyl-1,4-dihydroquinoxaline-2,3-dioneNR2B NMDA receptortraxoprodil mesylate

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory University, Atlanta, Georgia 30329, USA. dlwalke@emory.edu

Förderung

  • NIMH NIH HHS

Zitieren

APA

Walker, D. L., & Davis, M. (2008). Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test. Learning & Memory, 15(2), 67-74. https://doi.org/10.1101/lm.798908

Vancouver

Walker DL, Davis M. Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test. Learning & Memory. 2008;15(2):67-74. doi:10.1101/lm.798908

BibTeX
@article{Walker2008,
  author = {Walker, David L and Davis, Michael},
  title = {Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test},
  journal = {Learning & Memory},
  year = {2008},
  volume = {15},
  number = {2},
  pages = {67--74},
  doi = {10.1101/lm.798908}
}
Kostenlos starten →